- Home
- ANEB vs AIXI Comparison
ANEB vs AIXI Comparison
Compare ANEB & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- AIXI
- Stock Information
- Founded
- ANEB 2020
- AIXI 2001
- Country
- ANEB United States
- AIXI China
- Employees
- ANEB N/A
- AIXI N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- ANEB Health Care
- AIXI Technology
- Exchange
- ANEB Nasdaq
- AIXI Nasdaq
- Market Cap
- ANEB 36.7M
- AIXI 43.9M
- IPO Year
- ANEB 2021
- AIXI 2023
- Fundamental
- Price
- ANEB $0.98
- AIXI $2.78
- Analyst Decision
- ANEB Buy
- AIXI
- Analyst Count
- ANEB 1
- AIXI 0
- Target Price
- ANEB $8.00
- AIXI N/A
- AVG Volume (30 Days)
- ANEB 37.4K
- AIXI 93.8K
- Earning Date
- ANEB 05-14-2025
- AIXI 04-29-2025
- Dividend Yield
- ANEB N/A
- AIXI N/A
- EPS Growth
- ANEB N/A
- AIXI N/A
- EPS
- ANEB N/A
- AIXI N/A
- Revenue
- ANEB N/A
- AIXI $65,643,604.00
- Revenue This Year
- ANEB N/A
- AIXI $22.85
- Revenue Next Year
- ANEB N/A
- AIXI $22.70
- P/E Ratio
- ANEB N/A
- AIXI N/A
- Revenue Growth
- ANEB N/A
- AIXI 6.22
- 52 Week Low
- ANEB $0.80
- AIXI $2.06
- 52 Week High
- ANEB $3.30
- AIXI $16.56
- Technical
- Relative Strength Index (RSI)
- ANEB 35.89
- AIXI 39.14
- Support Level
- ANEB $0.94
- AIXI $2.35
- Resistance Level
- ANEB $1.12
- AIXI $2.90
- Average True Range (ATR)
- ANEB 0.14
- AIXI 0.43
- MACD
- ANEB -0.03
- AIXI -0.08
- Stochastic Oscillator
- ANEB 11.17
- AIXI 29.98
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.